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Background: Dynamic exchange provides a 
mechanism for rapidly reorganizing 
macromolecular structures. 
Results: Exchange of the focal adhesion targeted 
protein NEDD9 between the cytoplasm and focal 
adhesions is faster in the absence of Src kinase 
activity. 
Conclusion: Src kinase modulates the transit time 
of NEDD9 at focal adhesion sites. 
Significance: This is a new function for Src kinase 
in cell migration. 
 
ABSTRACT 
Dynamic exchange of molecules between the 
cytoplasm and integrin-based focal adhesions 
provides a rapid response system for 
modulating cell adhesion. Increased residency 
time of molecules that regulate adhesion 
turnover contributes to adhesion stability, 
ultimately determining migration speed across 
2-dimensional surfaces. In the present study we 
test the role of Src kinase in regulating dynamic 
exchange of the focal adhesion protein 
NEDD9/HEF1/Cas-L. Using either chemical 
inhibition or fibroblasts genetically null for Src 
together with Fluorescence Recovery After 
Photobleaching (FRAP), we find that Src 
significantly reduces NEDD9 exchange at focal 
adhesions. Analysis of NEDD9 mutant 
constructs with the two major Src interacting 
domains disabled revealed the greatest effects 
were due to the NEDD9 SH2 binding domain. 
This correlated with a significant change in 2D 
migratory speed. Given the emerging role of 
NEDD9 as a regulator of focal adhesion 
stability, the time of NEDD9 association at the 
focal adhesions is key in modulating rates of 
migration and invasion. Our study suggests that 
Src kinase activity determines NEDD9 
exchange at focal adhesions and may similarly 
modulate other focal adhesion-targeted Src 
substrates to regulate cell migration. 
Cell adhesion to the extra-cellular matrix 
is an essential component of cell migration and is 
chiefly determined by integrin receptor binding to 
extra-cellular matrix ligands. Ligand-bound and 
cross-linked integrins, together with the associated 
signalling molecules and polymerized actin 
filaments in the cell interior, comprise specialized 
adhesion sites known as focal adhesions. These 
sites both tether the cells to the underlying matrix 
and transmit signals bi-directionally between the 
matrix and the cell cytoplasm (1). During cell 
motility, focal adhesions must form and turnover, 
allowing grip and release of the underlying matrix 
and translocation of the cell bodies. Rapid 
exchange of proteins between focal adhesions and 
the cytoplasm (measured in time scales of seconds) 
facilitates the reorganization of the 
macromolecular focal adhesions in response to 
conditions that favour migration (2,3). The time 
with which focal adhesion stabilizing molecules 
reside in the focal adhesion (residency time) 
therefore represents an important mechanism to 
modulate adhesion to the extra-cellular matrix and 
consequently migratory behaviour.  
The balance of focal adhesion assembly 
versus turnover determines migration speed across 
2-dimensional (2D) planar surfaces (4-7). This is a 
biphasic relationship, where either too little or too 
much adhesion slows 2D cell speed, and maximal 
migration speeds are observed at intermediate 
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attachment strengths (8,9). Thus conditions which 
alter the turnover rate of focal adhesions can 
correspondingly tune cell migration speed. 
Investigations of a number of focal adhesion 
molecules have confirmed that many serve to 
regulate focal adhesion turnover rates (10). While 
a number of molecules stimulate focal adhesion 
turnover, our recent data have revealed that the 
focal adhesion associated molecule 
NEDD9/HEF1/Cas-L instead stabilizes focal 
adhesions and can thus tune 2D migration speed 
(11,12).  
NEDD9 is a docking protein at focal 
adhesions that is subject to extensive 
phosphorylation modification by Src kinase (13). 
NEDD9 encompasses multiple protein-protein 
interaction domains that facilitate the docking of 
interacting partner proteins, stimulating a variety 
of cellular processes, including a prominent pro-
migratory/pro-metastatic role (13,14). Recruitment 
to focal adhesions is achieved through interaction 
with focal adhesion kinase (FAK) resident at the 
focal adhesions (15). FAK then phosphorylates a 
tyrosine motif (DYDY) in the NEDD9 c-terminal 
domain that creates a binding site for Src (the Src 
binding domain SBD) (13). Once docked, Src 
phosphorylates up to 13 consensus tyrosine 
phosphorylation sites in the NEDD9 substrate 
binding domain (SH2BD). This creates docking 
sites for SH2-domain containing partner proteins 
and is an important determinant of NEDD9 
regulated cell migration (12,16-18). 
In addition to the well-established role for 
Src phosphorylation in stimulating NEDD9-
mediated signalling cascades, we hypothesized that 
NEDD9 phosphorylation by Src may also regulate 
the residency time at focal adhesions. Increased 
opportunities for interactions between NEDD9 and 
other focal adhesion molecules as a result of 
extensive phosphorylation by Src could increase 
the time in which NEDD9 is tethered at the focal 
adhesions by stabilizing interactions with partner 
molecules. While there have been a handful of 
studies investigating the exchange rates of focal 
adhesion molecules, at present there is little 
understanding of how this is controlled. We have 
employed Src/Yes/Fyn (Src)-/- mouse embryo 
fibroblasts (MEFs) and NEDD9 -/- MEFs to 
investigate the role of Src kinase in NEDD9 
dynamic exchange at focal adhesions. Our data 
indicate that Src regulates the transit time of 
NEDD9 at focal adhesions. 
 
 
 
EXPERIMENTAL PROCEDURES 
Cells and cell culture - Src/Yes/Fyn (SYF-/-) null 
and FAK -/- mouse embryo fibroblasts (MEFs) 
were from American Type Culture Collection 
(ATCC) and NEDD9 (NEDD9-/-) MEFs have 
been described (11). All lines were maintained in 
Dulbecco’s Modified Eagle’s Medium (DMEM) 
supplemented with either 10% foetal bovine serum 
(FBS) (Life Technologies), 1% 
penicillin/streptomycin (Invitrogen) and 2µg/ml 
fungizone (Life Technologies) or 15% FBS and 
1% antibiotic/antimycotic (Life Technologies), at 
370C and 5% CO2. 
Antibodies - Monoclonal anti-NEDD9, 
polyclonal anti-FAK (Cell Signalling Technology); 
monoclonal anti-paxillin and p130Cas (BD 
Transduction Laboratories); anti-Src (Clone 
GD11) (Millipore); monoclonal anti-GFP (Roche), 
monoclonal anti-GFP, polyclonal anti-Paxillin 
pY118 (Life Technologies)  anti-β-actin, anti-
HSP-70 (Sigma); horseradish peroxidase-
conjugated goat secondary antibodies for 
immunoblot analysis (Amersham Pharmacia 
Biotech) and; Cy3-conjugated donkey anti-rabbit 
and Cy5-conjugated donkey anti-mouse IgG 
secondary antibodies for immunofluorescence 
(Jackson Immunoresearch). 
Plasmids and protein expression - NEDD9 
fused to GFP has been previously described (19). 
QuikChange kit (Stratagene) was used to mutate 
NEDD9 Y629 and Y631 to phenylalanines 
(NEDD9.DFDF). Primer pairs: forward 5' 
GCTGGATGGATGACTT3’, reverse 
5’TCGAAGTCATCCATCCAGC 3' and forward 
5’CGATTTCGTCCACCTACAGGG3' and reverse 
5' CCCTGTAGGTGGACGAAA3’. SH2BD 
domain deletion was achieved by synthesizing the 
sequence encoding the first 67 amino acids (M1-
M67), flanked by EcoR1 and AvaI restriction sites, 
then joined by restriction enzyme-mediated 
ligation with the NEDD9 beginning at S358 
(deleting the intervening 290 residues). The mutant 
sequence was sub-cloned into the same GFP vector 
backbone as the wild-type sequence. All constructs 
were confirmed by DNA sequencing. Transient 
MEF cell transfection was achieved using a 
nucleofector (Amaxa) and MEF1 nucleofector kit 
(Lonza). 
Immunoprecipitation, immunoblot and 
immunofluorescence - Immunoprecipitation was 
performed using 1 mg of protein lysate extracted in 
NP-40 lysis buffer (50 mM Tris (pH 7.5) 150 mM 
NaCl, 5 mM EDTA, 1% NP-40) freshly sup- 
plemented with protease inhibitors (1 mM 
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NA3VO4, 1 mM PMSF, 1 μg/mL aprotinin, 1 
μg/mL leupeptin). Protein G agarose was swollen 
in 10 mM HEPES (pH 7.4) on ice for 30 min, then 
washed in PBS and resuspended at a concentration 
of 4 mg/ml in NP- lysis buffer supplemented with 
protease inhibitors. Cell lysates were pre-cleared 
with 4 mg of agarose and mixed end-over-end at 
4°C for 1 hour. Pre-cleared lysates were incubated 
with anti-GFP (Roche) or mouse IgG for 2 hours at 
4°C to which 4 mg of protein G agarose was added 
and incubated for a further 16 hours. 
Immunoprecipitates were washed three times with 
NP-40 lysis buffer (supplemented with inhibitors) 
and eluted in SDS-PAGE sample buffer.  For all 
other immunobloting PTY lysis buffer protein 
extraction and immunoblotting were performed as 
previously described (20). For 
immunofluorescence cells cultured overnight on 
glass coverslips were fixed in 4% 
paraformaldehyde (PFA) and permeabilized in 
PBS/0.5% bovine serum albumin and 0.2% Triton-
X. Coverslips were mounted with Fluorsave 
(Merck-Millipore). Confocal microscopy was 
performed using a Leica SP5 confocal, 63 X oil 
objective. Images were captured using the Leica 
LAS-AF software. Cells were imaged at a single 
optical plane corresponding to focal adhesion 
positions on the ventral surface.  
Fluorescence Recovery After 
Photobleaching (FRAP) - Transfected cells were 
cultured overnight at 37°C with 5% CO2 in 35mm 
glass bottom dishes (MatTek, Boston, MA, USA). 
Media was then exchanged for CO2-independent 
media supplemented with 15% FBS and 
antibiotic/antimycotic and cultures equilibrated at 
37°C for 1 hour. FRAP analysis was performed 
using either Leica SP5 confocal and 63 X oil 
objective (NEDD9 mutant constructs) or Olympus 
FV1000 confocal and 60 X oil objective (SYF-/- 
and PP2 experiments), both equipped with a 37°C 
environmental chamber. Focal adhesions were 
photobleached for 3 seconds with an argon laser at 
50%. Images of the bleached area were then 
recorded every 1.4 seconds over a minimum 60 
second period. Recovery rates were calculated and 
normalised to single control measurements taken 
per focal adhesion, using either the Leica 
supported software LAS-AF or the Olympus 
Fluoview software. FRAP analysis was performed 
on cells from 3 independent experiments on 
separate days and then pooled to obtain sufficient 
numbers of focal adhesions for analysis. Src 
inhibition with PP2 (Sigma Aldrich) was achieved 
by incubation with 2µM PP2 overnight prior to 
analysis. Statistical analysis was performed using 
GraphPad Prism. 
Live cell imaging, migration and 
spreading analysis - Time-lapse images of 
transfected cells at low confluence in a 35mm 
plastic dish were captured using an ORCA ERG 
cooled CCD camera (Hamamatsu SDR Clinical 
Technology NSW, Australia) and an Olympus 
IX81 inverted microscope equipped with a 37°C 
environmental chamber. Transmitted light images 
of transfected cells (identified by initial single 
fluorescence image) were captured every 5 
minutes over 6 hours. Cells undergoing division or 
apoptosis were excluded from analysis. Nuclear 
translocation was tracked in the time-lapse image 
stacks using Metamorph V6.3 software (Molecular 
Devices). 
 
RESULTS 
Src regulates NEDD9 exchange at focal 
adhesions. We first confirmed that NEDD9 
localization to focal adhesions does not require Src 
kinase activity by transfecting Src-/- MEFs with 
GFP-tagged NEDD9. NEDD9 robustly localized to 
focal adhesions in a similar pattern to that 
observed in NEDD9-/- MEFs, with strong 
concordance between the focal adhesion marker 
paxillin and GFP.NEDD9 sub-cellular distribution 
(Fig. 1A). NEDD9 is detected as two phospho-
forms by western blot (21,22) and exogenous 
GFP.NEDD9 similarly produces a doublet in 
NEDD9-/- and Src-/- MEFs (Fig. 1A). The small 
decrease in the upper form of NEDD9 in the Src-/- 
MEFS was inconsistent between experiments (data 
not shown). 
We next compared GFP-tagged NEDD9 
exchange at focal adhesions between Src-/- and 
NEDD9-/- MEFs by Fluorescence Recovery After 
Photobleaching (FRAP). For uniformity, all 
analyses were focused on focal adhesions in 
regions of protruding cell membrane. Notably, the 
recovery of GFP.NEDD9 appeared faster in the 
Src -/- MEFs (Figs 1B and 1C). Quantification of 
recovery rates confirmed that they were indeed 
significantly faster (Fig. 1D). To discount the 
possibility that the differences seen might be due 
to different cell backgrounds (Src-/- versus 
NEDD9-/- MEFs) GFP.NEDD9 recovery was next 
measured in NEDD9-/- MEFs treated with PP2, a 
chemical inhibitor of Src kinase. Importantly, 
NEDD9 fluorescence recovery in the presence of 
PP2 was significantly increased when compared to 
untreated NEDD9 -/- MEFs (Figs 1C and 1D). 
Since the Src-/- MEFs express endogenous 
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NEDD9, to rule out that the difference reflect 
changes in the total amount of NEDD9 protein, we 
next compared the dynamics of GFP.NEDD9 in 
NEDD-/- MEFs versus matched wild-type MEFs. 
This revealed identical recovery kinetics between 
the NEDD9-/-MEFs and the wild-type MEFs 
(Figure 1E). Together these data suggest an 
important role for Src in determining NEDD9 
exchange at focal adhesions. 
For comparison, we examined 
GFP.NEDD9 with the C-terminal domain deleted 
(NEDD9.∆CT). This domain encompasses the 
focal adhesion targeting domain (23) and is 
required for focal adhesion localization (24). Cells 
were co-transfected with mcherry-tagged paxillin 
to identify the focal adhesion region of interest for 
photobleaching (Figs 2A and 2B). As anticipated, 
the NEDD9.∆CT construct exhibited faster 
exchange in the region of the focal adhesions (Figs 
2C and 2D). However, this did not simply reflect 
free diffusion, since the same analysis of unfused 
GFP at focal adhesions marked by mcherry 
paxillin showed an ~ 10-fold higher exchange rate 
(GFPNEDD9.∆CT: K = 0.35 ± 0.018 versus GFP: 
K = 2.98 ± 0.24, ***p<0.001, Students’ t-test). 
Consequently, despite the lack of the focal 
adhesion targeting domain (thereby abrogating 
GFP-positive adhesions), the molecular dynamics 
were slowed around the focal adhesion. Together 
this data suggests that localization (concentrated 
appearance at a focal adhesion) is separable from 
the rate of exchange between the focal adhesion 
juxtamembrane region and the cytoplasm. 
The NEDD9 SH2 binding domain 
dominantly regulates exchange. Src stimulates 
focal adhesion turnover (10), and regulates actin 
filament dynamics (25) in turn controlling acto-
myosin force that determines adhesion molecule 
exchange (3). Potentially, therefore, faster NEDD9 
exchange in the absence of Src activity may have 
been secondary to altered actin filament dynamics 
or Src-dependent focal adhesion turnover. To rule 
this out, we quantified the role of the two direct 
NEDD9 Src target sites: the SBD (DYDY) and the 
SH2BD (26). First, the SBD tyrosines were 
mutated to phenylalanine, to prevent 
phosphorylation (DFDF) (Fig. 3A). Note that 
NEDD9 does not contain the additional Src SH3 
binding that forms the Src bipartite binding 
domain in other Cas family proteins (13) and so 
only binds Src via the tyrosine motif. 
NEDD9.DFDF generates the same doublet pattern 
on western blot as seen for the wild-type sequence 
(Fig. 3A). Immunofluorescence confirmed co-
localization of the mutant protein with paxillin-
positive focal adhesions at the cell periphery and 
ventral surface (Fig. 3B). FRAP analysis of 
GFP.NEDD9.DFDF positive focal adhesions 
revealed a significantly increased fluorescence 
recovery rate compared to wild type NEDD9 (Figs 
4A-4C). Thus phosphorylation of the DYDY motif 
and subsequent Src kinase docking may slow the 
rate of NEDD9 molecular exchange at focal 
adhesions. 
Next, we analysed a NEDD9 SH2BD 
deleted mutant (NEDD9∆SH2BD). As this also 
deletes the NEDD9 antibody-binding epitope, anti-
p130Cas antibodies which bind a conserved 
epitope (19) were used to confirm expression of 
the truncated protein (Fig. 3A). Importantly, loss 
of the substrate binding domain does not affect 
NEDD9 targeting to the focal adhesions (Fig. 3B). 
GFP-tagged NEDD9∆SH2BD co-localized at all 
regions of paxillin-positive focal adhesions (Fig. 
3B). FRAP analysis of this construct revealed a 
striking increase in the rate of fluorescence 
recovery (Figs 4A-4C). Notably, this was also 
significantly faster than the recovery rate of 
NEDD9.DFDF (Fig. 4C). We then questioned 
whether the NEDD9 mutant proteins exhibited an 
altered mobile fraction, defined as the maximum 
plateau of fluorescence recovery. While analysis 
revealed a significant difference between the 
maximum plateaus of the NEDD9∆SH2BD versus 
NEDD9.DFDF and NEDD9 (Fig. 4D), the 
magnitude of the difference was very small (80% 
and 82% versus 80% and 79%). Thus in each case 
~ 20% of the total pool remains immobile, 
agreeing with earlier descriptions of the stable 
focal adhesion fraction over a similar time course 
(27). Notably, the difference between 
GFP.NEDD9 in the NEDD9-/- MEFs versus the 
Src-/- MEFs was considerably larger (Fig. 1C). 
The relatively smaller difference between the 
mutant forms and the PP2-treated cells with wild-
type NEDD9 suggests differences observed in the 
Src-/- MEFs may be cell type specific and suggest 
that the most important effects of Src may be on 
exchange. Our data suggest a hierarchy of Src 
kinase effects: the substrate binding domain has 
the greatest effects on NEDD9 dynamics at focal 
adhesions, while the Src SH2 binding motif has a 
more limited role. 
Interaction with FAK regulates NEDD9 
focal adhesion targeting. Given the differences in 
molecular exchange between wild-type NEDD9, 
NEDD9∆CT, NEDD9.DFDF and 
NEDD9∆SH2BD we questioned whether these 
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differences might reflect differential interaction 
with NEDD9 partner molecules. As FAK is a well-
established partner of NEDD9 (13), FAK 
interaction with each of the NEDD9 constructs was 
assessed by co-immunoprecipitation. This revealed 
that NEDD9, NEDD9.DFDF and  
NEDD9∆SH2BD show equivalent and robust 
interaction with FAK (Figure 5A). By contrast 
considerably less FAK co-immunoprecipitates 
with NEDD9∆CT. Thus we next confirmed that 
FAK is required for NEDD9 targeting to focal 
adhesions, by analysing GFP.NEDD9 sub-cellular 
distribution in FAK-/- fibroblasts. This revealed 
that GFP.NEDD9 does not target to focal 
adhesions in the absence of FAK expression 
(Figure 5B). Importantly, exogenous expression of 
FAK restores NEDD9 targeting to focal adhesions 
(Figure 5B). Based on these findings we suggest 
that the interaction between NEDD9∆CT and FAK 
may attenuate NEDD9∆CT dynamics but requires 
the NEDD9 c-terminal domain in order to anchor 
NEDD9 at the focal adhesions. 
NEDD9 SH2BD affects focal adhesion 
signalling. Next we questioned the effect of the 
altered rates of molecular exchange on focal 
adhesion morphology and signalling.  Comparison 
of the total number of focal adhesions revealed that 
neither NEDD9.DFDF nor NEDD9∆SH2BD 
altered the number of focal adhesions per cell 
(Figure 6A and 6B). However, focal adhesions in 
cells expressing NEDD9∆SH2BD were 
significantly larger (Figure 6C). To investigate 
whether expression of the NEDD9 mutant 
constructs altered focal adhesion signalling, we 
analysed paxillin phosphorylation at focal 
adhesions. Ratio imaging of focal adhesions co-
immunostained with antibodies to total paxillin 
and paxillin phosphorylated at Y118 suggested that 
paxillin phosphorylation at focal adhesions is 
reduced in cells expressing NEDD9.DFDF and 
NEDD9∆SH2BD (Figure 6A). Semi-quantitative 
measurement of the ratio of phosphorylated 
paxillin at focal adhesions confirmed this 
observation (Figure 6D). 
The SH2BD mediates cell migration. 
Faster focal adhesion turnover due to the absence 
of NEDD9 generates faster 2D cell migration 
speeds in NEDD9 -/- MEFs; conversely, in the 
presence of NEDD9 focal adhesions are stabilized 
resulting in slower migration speeds (11). 
Agreeing with this earlier data, exogenous NEDD9 
expression in the NEDD9-/- MEFs slows cell 
progression (Fig. 7A), and individual cell 
migration speed (Fig. 7B). We then hypothesized 
that conditions of more rapid NEDD9 exchange at 
focal adhesions should equate to increased cell 
migration speed. Indeed, cells expressing 
NEDD9∆SH2BD displayed a greater mean 
squared displacement (MSD) than either 
GFP.NEDD9 or GFP.NEDD9DFDF (Fig. 7C) and 
significantly faster cell speeds (Fig. 7D). These 
findings agree with other studies that have high-
lighted the role of the NEDD9 SH2BD in 
regulating cell migration (12,16-18).  
  
DISCUSSION 
NEDD9 localization to focal adhesions is 
key to the function of this protein in cell migration 
however the molecular regulation of NEDD9 
exchange at focal adhesions has not been 
previously explored. In the present study, we 
found that Src kinase activity is required to slow 
NEDD9 exchange at focal adhesions and deletion 
of the NEDD9 domain that is targeted by Src 
significantly increases the speed of NEDD9 
exchange. We therefore propose that Src 
phosphorylation of NEDD9 is an important 
determinant of NEDD9 residency time at focal 
adhesions.  
While it has long been known that focal 
adhesions are regulated via assembly and turnover, 
the constant molecular exchange between focal 
adhesion-associated molecules and their 
cytoplasmic counterparts is a more recently 
recognized control mechanism (2). There is 
precedence for signalling-dependent regulation of 
focal adhesion residency time. Calcium flux slows 
FAK recovery, thus prolonging FAK association at 
focal adhesions (28), while phosphorylation of the 
FAK auto-phosphorylation site (Y397) was 
sufficient to increase residency time (29). We have 
now shown that Src regulates the residency time of 
NEDD9 at focal adhesions. Since Src is a major 
regulator of focal adhesion disassembly, including 
directly regulating FAK activity and acto-myosin 
contractility, it was necessary to test whether the 
effects on NEDD9 were either direct or secondary 
to other Src targets. Importantly, the demonstration 
that the NEDD9 SH2BD is required to regulate the 
rate of NEDD9 molecular exchange confirmed that 
the effects seen were direct.  
Focal adhesion components examined to 
date exist in at least two states, an immobile 
fraction and a fraction that exchanges between the 
cytoplasm and the focal adhesion. Recent reports 
have also suggested a third behaviour, where 
attenuated diffusion of focal adhesion components 
in the juxtamembrane region close to the focal 
adhesions serves as a pool of molecules for 
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exchange with the focal adhesions (27). Proteins 
that freely diffuse at focal adhesions should have a 
mobile fraction of 100% and a reduced mobile 
fraction suggests strong binding to fixed 
components (30). We found that NEDD9 has a 
relatively high mobile fraction, with ~ 80% of the 
total pool recovered post-bleaching. The related 
Cas family protein p130Cas (26) has also been 
shown to have a high mobile fraction, as compared 
for example to paxillin (31). Interestingly, paxillin 
contains multiple LIM domains that mediate direct 
binding to actin (32). Conceivably, the reduced 
mobility of paxillin at focal adhesions may be due 
to paxillin binding to a stable actin core. By 
contrast, NEDD9 and p130Cas may not interact 
with stable structural elements of the focal 
adhesions and hence have relatively high mobile 
fractions. Notably, the magnitude of difference 
between the mobile fractions of the NEDD9 
mutant proteins was very small, suggesting that the 
NEDD9 SBD and SH2BD have limited impact on 
the total fraction of mobile NEDD9 at focal 
adhesions.  
The rate of protein recovery at the focal 
adhesions depends on the stability of the 
interaction with proteins in the focal adhesions 
(30). In line with this, deletion of the NEDD9 c-
terminal domain reduces interaction with FAK and 
this mutant exhibits rapid exchange in the vicinity 
of the focal adhesions. We note that while 
mutation of the SBD resulted in significantly faster 
recovery rates than observed for the wild-type 
molecule, deletion of the SH2BD resulted in an 
even faster recovery rate than the SBD mutant. 
Moreover, the SBD mutation had no significant 
effect on NEDD9-mediated 2D cell migration, but 
the SH2BD mutation significantly altered the 
NEDD9-mediated migration effects. Thus, our data 
suggest that Src-mediated phosphorylation of sites 
in the NEDD9 SH2BD may stabilize interactions 
between NEDD9 and proteins resident at the focal 
adhesions. We have previously shown that 
NEDD9 stabilizes focal adhesions (11) and 
therefore we suggest that increased residency time 
of NEDD9 at the focal adhesions facilitates 
NEDD9-mediated focal adhesion stabilization. 
Similarly, increased FAK residency time –
mediated by Y397 phosphorylation (29) – 
promotes the focal adhesion disassembly function 
of FAK by allowing increased time for FAK’s 
action on its cognate partners. Thus together, our 
data suggest that the SH2BD serves an important 
function in regulating the rate of NEDD9 exchange 
at the focal adhesions, thereby determining focal 
adhesion stability and subsequent cell migration 
speeds. 
Given that there are multiple consensus 
tyrosine phosphorylation sites contained within the 
NEDD9 substrate domain, it is possible that either 
multiple tyrosine phosphorylations are required for 
stabilizing NEDD9 interaction at the focal 
adhesions or individual phosphorylations may be 
important. A high stringency scan for putative SH2 
interactors at the Scansite website reveals 
predicted motifs for a number of proteins including 
Abl, Itk and Lck kinases and the adaptor molecules 
Crk, Nck and Grb2 (33). Our data suggests that 
interaction with one or more of these proteins, and 
potentially other as yet unidentified partners, 
following Src-mediated phosphorylation 
determines the stability of NEDD9 association at 
focal adhesions.  
The present study expands the previously 
ascribed role for Src kinase in focal adhesion 
turnover (25), to a novel role in regulating 
molecule exchange rates at focal adhesions. Given 
the large array of Src substrates at focal adhesions 
(34), we suggest that this may prove to be a more 
general function of Src at focal adhesions, 
identifying a new biological role for this important 
enzyme (7,12,16-18). 
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FIGURE LEGENDS 
 
FIGURE 1. Src regulates NEDD9 molecular exchange. (a) Confocal images of GFP.NEDD9 in NEDD9 -
/- and Src -/- MEFs. Paxillin immunostaining identifies focal adhesions (centre panels) and 
NEDD9/paxillin co-localisation is shown in merged images (right panels). Scale bars = 20 µm. 
Immunoblots were probed with indicated antibodies. Antibodies to HSP-70 used as loading control. (b) 
Representative focal adhesions prior to photobleaching (left panel), immediately post-photobleaching (0”) 
and throughout fluorescence recovery (5-40”). (c) Recovery kinetics of the indicated GFP-tagged 
constructs. Data plots compare normalised fluorescence recovery for each construct. (d) Rates of 
GFP.NEDD9 fluorescence recovery post photobleaching for the indicated conditions. Data represent the 
mean values of >13 focal adhesions per construct and error bars show SEM. ** p<0.01 and *** p<0.001, 
one-way ANOVA with Tukey’s Multiple Comparison post-test. (e) Fluorescence recovery of 
GFP.NEDD9 is identical between NEDD9-/- MEFs (black squares) versus wild-type (WT) MEFs (white 
squares). 
 
FIGURE 2. FRAP analysis of NEDD9∆CT. (a) Schematic of NEDD9 wild-type (WT) sequence and C-
terminal domain deletion mutant (NEDD9∆CT). (b) As NEDD9∆CT does not localize to focal adhesions, 
cells were co-transfected with mcherry-tagged paxillin to detect focal adhesions. This was used to mask 
the relevant areas in the GFP images to analyse NEDD9∆CT dynamics. Shown is an example of mcherry 
paxillin used to identify relevant areas for photo-bleaching the GFP signal. Scale bars = 5 µm. (c) 
Fluorescence recovery of GFP.NEDD9 (black squares) versus GFP.NEDD9∆CT (white squares) in 
NEDD9-/- MEFs. (d) Fluorescence recovery rates for the indicated constructs. Data represent the mean of 
>43 focal adhesions per construct and error bars show SEM. *** p<0.001, Students’ t-test. 
 
FIGURE 3. NEDD9 Src SH2 binding motif and substrate binding domain are not required for focal 
adhesion localization. (a) Schematic of the Src binding site mutant (NEDD9.DFDF) and SH2 binding 
domain deleted mutant (NEDD9.∆SH2BD). Cartoons show the SH3 domain, the substrate binding domain 
(SH2BD), the serine rich region (SRR) and the C-terminus (CT). The NEDD9 antibody binding epitope 
(*) and p130Cas antibody cross-reacting epitope (**) are indicated. As the SH2BD encompasses the anti-
NEDD9 antibody epitope, anti-p130Cas antibodies (conserved antibody epitope in the C-terminus of 
NEDD9) were used to confirm expression of NEDD9∆SH2BD (immunoblots on the right). (b) NEDD9-/- 
MEFs transfected with the indicated constructs were immunostained with paxillin to identify focal 
adhesions (centre panels), NEDD9 and paxillin co-localization shown in the merged images (right panels). 
Scale bars = 20µm.  
 
FIGURE 4. NEDD9 Src SH2 binding motif and substrate binding domain mediate molecular exchange. 
(a) Representative focal adhesions from NEDD9-/- MEFs expressing the indicated GFP fusion proteins, 
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shown prior to photobleaching (left panel), following photobleaching (0”) and throughout the recovery 
period (5-60”). Scale bars = 5 µm. (b) The recovery kinetics of the indicated GFP-tagged constructs. Data 
plots show normalised fluorescence recovery for each construct. (c) Fluorescence recovery rates post-
photobleaching for each construct. (d). Average mobile fractions. Note that error bars (SEM) are present, 
but not visible due to small size. Data represent the mean values of >45 focal adhesions per construct and 
error bars show SEM; *** p < 0.001, *p < 0.05, NS = not significant; one-way ANOVA with Tukey’s 
Multiple Comparison test. 
 
Figure 5. NEDD9 interaction with FAK and targeting to focal adhesions. (a) NEDD9-/- MEFs were 
transfected with the indicated GFP-tagged NEDD9 constructs. Exogenous GFP-tagged proteins were 
immunoprecipitated (IP) with anti-GFP antibodies and western blots of immunoprecipitates probed with 
the indicated antibodies (anti-FAK and anti-GFP). Western blots of whole cell lysates (WCL) were probed 
as indicated to demonstrate protein expression prior to IP. (b) Micrographs show confocal images of FAK-
/- MEFs expressing GFP.NEDD9 alone, or cotransfected with an exogenous FAK expression construct 
(lower panels). Cells were immunostained with paxillin antibodies (centre panels). Scale bars = 20 µm. 
Immunoblots confirm expression of the exogenous molecules in FAK-/- cells expressing GFP.NEDD9 
alone, or in cells reconstituted with FAK. Antibodies to HSP-70 used as loading control.  
 
Figure 6. Focal adhesion phenotypes and signalling. (a) NEDD9-/- MEFs transfected with the indicated 
GFP-tagged constructs, fixed and co-immunostained for paxillin (red) and phospho-paxillin (pY118, 
blue). The third column shows the merge of GFP/paxillin/phospho-paxillin staining. Final panels show 
paxillin phosphorylation represented by ratio imaging. Insets show magnified regions of focal adhesions. 
Yellow hues indicate areas of increased paxillin phosphorylation. (b) The average number of focal 
adhesions per cell. (c) The sum of the focal adhesion area expressed as a percentage of the total cell area. 
Data points represent the average value for each cell. (d) Distribution of the ratios of phosphorylated 
paxillin at focal adhesions. Data points show the average value for all focal adhesions in each cell and 
horizontal bars indicate the mean of each population. n>45 cells examined for each parameter. *** p < 
0.001, NS = not significant; one-way ANOVA with Tukey’s Multiple Comparison test. 
 
FIGURE 7. SH2BD mediates regulation of cell migration. (a) Transfected NEDD9-/- MEFs were 
analysed by time-lapse imaging over a 6 hour period. Mean Squared Displacements (MSD) were 
calculated from cell trajectories. (b) Plots of individual migration speeds. Horizontal bars indicate the 
average speed (n>150 cells per construct). *** p<0.0001 Students’ t-test. (c) MSD calculated for NEDD9-
/- MEFs expressing the indicated GFP-fused NEDD9 proteins. (d) Plots of individual migration speeds 
(n>150 cells per construct). ** p<0.001 one-way ANOVA with Tukey’s Multiple Comparison post-test.    
 
 







